Project Grant R35GM166254
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $436,361.00 under the Biomedical Research and Research Training program (CFDA 93.859) to support a five-year project (August 1, 2025 – July 31, 2030) focused on advancing protein structure determination methodologies. The Research Foundation for the State University of New York, serving as the fiscal agent for research conducted in Buffalo, will develop innovative computational algorithms and...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Stony Brook University $432,892 under the Biomedical Research and Research Training program (CFDA 93.859) beginning June 1, 2026, with completion targeted for May 31, 2031. This Project Grant funds a five-year research initiative led by investigators at Stony Brook to elucidate the structural organization and environmental adaptation mechanisms of the mycobacterial cell envelope—specifically addressing...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $343,007 to The Research Foundation For The State University of New York on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support a research project titled "Characterizing Glycosylation Regulatory Networks Using Single-Cell Multiomics and Mathematical Modeling." The research, to be performed in Buffalo, NY, will extend through March 31,...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Rochester a $802,176 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, with a completion date of June 30, 2030. The award funds a five-year investigation into the dynamics of cell-matrix mechanical communication during morphogenesis, with the principal objective of understanding how mechanical signals from...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $825,000 Project Grant to Massachusetts General Hospital's Research Management Division on August 7, 2025, under the Biomedical Research and Research Training program (CFDA 93.859). The five-year award, scheduled for completion on June 30, 2030, supports investigator-initiated research to dissect the molecular mechanisms by which macrophages regulate stem and progenitor cell quality assurance...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Stony Brook University $432,569.00 under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the regulatory mechanisms of extracellular particle (EP)-mediated intercellular signaling. The award, effective March 5, 2026 and extending through February 28, 2031, funds fundamental research that will elucidate how cells release and utilize extracellular particles as...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded UC San Diego a $249,000 Project Grant effective September 1, 2025, through August 31, 2028, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports fundamental research investigating how biophysical cues—including mechanical confinement, matrix properties, and cellular morphology—regulate macrophage and T-cell behavior in tumor microenvironments. The research...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Wistar Institute of Anatomy and Biology a Project Grant totaling $506,550 under the Biomedical Research and Research Training program (CFDA 93.859) to investigate mechanisms controlling the development of TIM4+ macrophages. The award period runs from April 1, 2026, through March 31, 2031. The research addresses a fundamental biological question regarding post-differentiation development of...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $455,610 to The Research Foundation For The State University Of New York under the Biomedical Research and Research Training program (CFDA 93.859) on July 1, 2026, for a two-year project extending through June 30, 2028. The project, conducted at SUNY at Binghamton in Binghamton, New York, focuses on developing SHEPRD (Sonic Hedgehog for EV-POI Registry and Dispersal), a novel technology...
- Federal Project Grant Award Summary Rockefeller University received a $395,499 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 1, 2026, with completion targeted for February 28, 2031. This award funds investigator-initiated basic research on cytoskeletal force-sensing mechanisms and mechanotransduction—the process by which cells convert mechanical environmental cues into...
Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $432,844 to The Research Foundation for the State University of New York (RF SUNY), administered through its Sponsored Projects Services division, under the Biomedical Research and Research Training program (CFDA 93.859). The award, dated July 10, 2026, funds a research initiative titled "Biophysical Regulation of Macrophages Through Engineered Material Platforms" with performance in Buffalo, NY, extending through March 31, 2031. The research develops innovative biomaterial platforms and investigative tools to elucidate how mechanical properties in the cellular microenvironment—including stiffness, spatial geometry, viscoelasticity, and intracellular forces—regulate macrophage function and polarization states relevant to inflammation, tissue repair, fibrosis, and cancer. The research delivers three primary technical innovations: (1) curvature-engineered platforms spanning fibril- to tissue-scale geometries to dissect cytoskeletal organization and transcriptional pathways; (2) viscoelastic hydrogels under cyclic loading to identify mechanical "tipping points" between regenerative and fibrotic macrophage polarization; and (3) intracellular nanomaterial actuators to test direct cytoskeletal force effects on inflammatory and fibrotic gene expression. These engineered platforms serve dual purposes as foundational research tools to establish mechanoimmunology principles and as translational blueprints for potential therapeutics—including fibrosis-suppressing scaffolds, wound-healing-accelerating implants, and chronic inflammation modulators. Outputs are benchmarked against macrophage states from in vivo injury and fibrotic datasets to ensure physiologic relevance and translational applicability.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $432.8k | 7/6/26 |